Literature DB >> 20070513

Occult hepatitis C virus infection: what does it mean?

Tram N Q Pham1, Carla S Coffin, Tomasz I Michalak.   

Abstract

Occult hepatitis C virus infection (OCI) is a recently identified entity of which the existence became evident when nucleic acid amplification assays of enhanced sensitivity were introduced for the detection of hepatitis C virus (HCV) genome and its replication. This form of HCV infection has been found to persist in the presence of antibodies against HCV and normal levels of liver enzymes for years after spontaneous or antiviral therapy-induced resolution of hepatitis C and, therefore, can be termed as secondary OCI. HCV RNA in OCI circulate at fluctuating levels normally not exceeding 200 genome copies per millilitre of serum or plasma, while low levels of virus genome and its replicative intermediate RNA-negative strand are detectable in the liver and, importantly, immune cells, which provide an opportunity to detect active virus replication without the need for acquiring a liver biopsy. In addition to secondary OCI, a form of OCI accompanied by persistently moderately elevated serum liver enzymes in the absence of antibodies to HCV, which can be termed as cryptogenic OCI, has also been described. The current understanding of the nature and characteristics of OCI, methods and pitfalls of its detection, as well as the documented and expected pathological consequences of OCI will be summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070513     DOI: 10.1111/j.1478-3231.2009.02193.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  21 in total

1.  New perspectives in occult hepatitis C virus infection.

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Occult hepatitis C virus infection and its relevance in clinical practice.

Authors:  Tram Nq Pham; Tomasz I Michalak
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

Review 3.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

4.  Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.

Authors:  Brenda Y Hernandez; Xuemei Zhu; Sandi Kwee; Owen T M Chan; Naoky Tsai; Gordon Okimoto; David Horio; Katherine A McGlynn; Sean Altekruse; Linda L Wong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

Review 5.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Direct effects of hepatitis C virus on the lymphoid cells.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

7.  Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.

Authors:  Mahmoud A Khattab; Yehia Zakaria; Eslam Sadek; Aliaa S Abd El Fatah; Magdy Fouad; Muhammed Khattab; Hend M Moness; Nashwa Mohamed Adel; Elham Ahmed
Journal:  Clin Exp Med       Date:  2022-01-23       Impact factor: 3.984

8.  Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.

Authors:  Georgia Skardasi; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

9.  Fatal Hepatitis C after Chemotherapy in a Patient with Malignant Lymphoma: Possible Reactivation of Seronegative Occult Hepatitis C Virus Infection Due to Chemotherapy.

Authors:  Kaname Miyashita; Yui Hongo; Akihiko Nakashima; Seiya Kato; Hironori Kusano; Shusuke Morizono; Nobuhiko Higashi
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

10.  Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.

Authors:  Samar Samir Youssef; Aml S Nasr; Taher El Zanaty; Rasha Sayed El Rawi; Mervat M Mattar
Journal:  Hepat Res Treat       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.